PSMA PET-Guided Progression-Directed Radiotherapy for Oligoprogressive Prostate Cancer

Abroad (travel likely)Recruiting

Conditions

Oligoprogressive Prostate Cancer · Metastatic Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Affidea Nu-Med Cancer Diagnostics and Therapy Center, Zamość, Lublin Voivodeship, Poland
Contact: Study coordinator (Mateusz Bilski, MD, PhD) · mateusz.bilski@affidea.com · 84 535 99 10
Contact: Study coordinator (Paulina Kleban) · paulina.kleban@affidea.com · 84 535 99 10
Contact: Principal Investigator (Mateusz Bilski, MD, PhD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

Prostate Cancer · Oligoprogressive · Urothelial Carcinoma

Abroad (travel likely)Recruiting

Sacramento, United States

Stereotactic Magnetic Resonance Guided Radiation Therapy

Pancreas Cancer · Lung Cancer · Renal Cancer

Abroad (travel likely)Recruiting

Boston, United States · Boston, United States

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

Castration-resistant Prostate Cancer · Oligoprogressive

Abroad (travel likely)RecruitingPHASE3

Leuven, Belgium

The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

Prostate Cancer (Adenocarcinoma) · OligoProgressive Metastatic Disease · Castration Resistant Metastatic Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Groningen, Netherlands · Nijmegen, Netherlands